PCM
CELG

Prelude Capital Management’s Celgene Corp CELG Stock Holding History

Prelude Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14,100
Closed -$1.4M – 2465
2019
Q3 		$1.4M Buy
14,100
+11,900
+541% +$1.13M 0.06% 253
2019
Q2 		$203K Sell
2,200
-54,800
-96% -$5.2M 0.01% 727
2019
Q1 		$5.38M Buy
+57,000
New +$4.98M 0.3% 56
2013
Q4 		– Sell
-2,000
Closed -$154K – 2267
2013
Q3 		$154K Buy
+2,000
New +$140K 0.02% 613

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Prelude Capital Management's CELG Position: Q4 2019 in Review

Prelude Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 428,244 shares — an estimated $42.5M sold.

Prelude Capital Management first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $47.4M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Prelude Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Prelude Capital Management sold 428,244 Celgene Corp shares in Q4 2019, an estimated $42.5M.
  • Prelude Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
  • Prelude Capital Management's Celgene Corp position peaked at $47.4M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.